Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blind-placebo Controlled Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 in Participants With Ankylosing Spondylitis (AS)

NCT01061723 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01061723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01061723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blind-placebo Controlled Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 in Participants With Ankylosing Spondylitis (AS)
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
June 30, 2011
Enrollment
301 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis